IDEXX Net Income Per Share from 2010 to 2024

IDXX Stock  USD 506.38  1.28  0.25%   
IDEXX Laboratories Net Income Per Share yearly trend continues to be fairly stable with very little volatility. Net Income Per Share is likely to outpace its year average in 2024. During the period from 2010 to 2024, IDEXX Laboratories Net Income Per Share regression line of annual values had r-squared of  0.92 and arithmetic mean of  4.54. View All Fundamentals
 
Net Income Per Share  
First Reported
2010-12-31
Previous Quarter
10.17313943
Current Value
10.68
Quarterly Volatility
3.50128978
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check IDEXX Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IDEXX Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 120.7 M, Interest Expense of 37.7 M or Total Revenue of 3.8 B, as well as many indicators such as Price To Sales Ratio of 13.22, Dividend Yield of 0.0 or PTB Ratio of 32.61. IDEXX financial statements analysis is a perfect complement when working with IDEXX Laboratories Valuation or Volatility modules.
  
Check out the analysis of IDEXX Laboratories Correlation against competitors.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

Latest IDEXX Laboratories' Net Income Per Share Growth Pattern

Below is the plot of the Net Income Per Share of IDEXX Laboratories over the last few years. It is IDEXX Laboratories' Net Income Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IDEXX Laboratories' overall financial position and show how it may be relating to other accounts over time.
Net Income Per Share10 Years Trend
Slightly volatile
   Net Income Per Share   
       Timeline  

IDEXX Net Income Per Share Regression Statistics

Arithmetic Mean4.54
Geometric Mean2.80
Coefficient Of Variation77.17
Mean Deviation2.97
Median3.00
Standard Deviation3.50
Sample Variance12.26
Range10.64
R-Value0.96
Mean Square Error1.08
R-Squared0.92
Slope0.75
Total Sum of Squares171.63

IDEXX Net Income Per Share History

2024 10.68
2023 10.17
2022 8.12
2021 8.74
2020 6.82
2019 4.97
2018 4.34

About IDEXX Laboratories Financial Statements

IDEXX Laboratories investors use historical fundamental indicators, such as IDEXX Laboratories' Net Income Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in IDEXX Laboratories. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Income Per Share 10.17  10.68 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for IDEXX Stock Analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.